BDNF and depressive symptom measurement: It was consistent with a previous study that reported BDNF release within the mPFC is necessary for the antidepressant actions of ketamine.[57] Moreover, in this study, supplementation of BDNF in the dLS or overexpression of AAV‐BDNF in the LC could significantly alleviate the depression‐like behaviors caused by CSDS.